论文信息 - Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer - 字舞流文

Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer

[This corrects the article DOI: 10.1371/journal.pone.0067581.].

C. Croce | G. Romano | G. Nuovo | Young-Jun Jeon | Gianpiero di Leva | M. Garofalo | H. Alder | P. Secchiero | P. Nana-Sinkam | N. Nazaryan | P. Joshi | Justin D Middleton | M. Crawford | Melissa Crawford

[1] C. Croce,et al. Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer , 2015, PloS one.

[2] C. Croce,et al. MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer , 2013, PloS one.

[3] C. Croce,et al. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222 , 2012, Oncogene.

[4] J. Sun,et al. EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers , 2011, Nature Medicine.

[5] Hansjuerg Alder,et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. , 2009, Cancer cell.

[6] Bernat Gel,et al. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. , 2009, Carcinogenesis.

[7] C. Croce,et al. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer , 2008, Oncogene.

[8] J. Bauman,et al. Antagonism of Platelet-Derived Growth Factor Receptor in Non–Small Cell Lung Cancer: Rationale and Investigations , 2007, Clinical Cancer Research.